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Abstract Neopterin is synthesized by human monocyte-derived
macrophages primarily upon stimulation with the cytokine in-
terferon-Q. We studied the in£uence of neopterin on the gener-
ation of reactive oxygen species (ROS) in human peripheral
blood neutrophils. Radical formation was measured using a bio-
chemiluminometer. Neutrophils were isolated from peripheral
blood of healthy donors. The generation of ROS by neutrophils
suspended in Earl’s solution (pH=7.4) at 37‡C was investigated
by monitoring of chemiluminescence using luminol and lucigenin
as light emitters. Neopterin induced chemiluminescence in sus-
pensions of neutrophils in the presence of luminol, but not of
lucigenin. Neopterin a¡ected only adhesive cells. Addition of
neopterin into the suspension of the cells involving D-mannitol,
L-histidine and diazabicyclo[2.2.2]octane (DABCO) decreased
luminol-dependent chemiluminescence (LDCL) of the neutro-
phils. The action of superoxide dismutase (SOD) and 2-phe-
nyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide (PTIO) re-
duced neopterin-induced LDCL of neutrophils. Data suggest
that neutrophils respond on exposure to neopterin with addi-
tional generation of singlet oxygen, hydroxyl radical and nitric
oxide by nicotinamide adenine dinucleotide phosphate
(NADPH)-independent pathways.
: 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Neopterin is a pyrazino-pyrimidine derivative, namely
2-amino-4-hydroxy-(1P,2P,3P-trihydroxypropyl)-pteridine, bio-
synthetically derived from guanosine triphosphate (GTP). En-
zyme GTP-cyclohydrolase I, which is inducible by cytokine
interferon-Q, converts GTP to 7,8-dihydroneopterin triphos-
phate, which in turn is transformed to 7,8-dihydroneopterin
and neopterin in human/primate macrophages and dendritic
cells [1,2]. Measurement of neopterin concentrations is useful
to monitor cell-mediated (Th1-type) immune activation [3], in
laboratory diagnosis the determination of neopterin concen-
trations in serum, urine, and cerebrospinal £uid can be ap-
plied, e.g. for early detection of immunological complications
after allotransplantation or to predict prognosis in human
immunode¢ciency virus (HIV) infection or malignant diseases
[3,4].
Experiments have shown that neopterin is capable to en-
hance the oxidative potential of reactive oxygen species (ROS)
produced from immunocompetent cells [5^7]. In parallel, neo-
pterin was found to also inhibit activity of xanthine oxidase
and reduced nicotinamide adenine dinucleotide phosphate
(NADPH)-oxidase [8^10]. Therefore neopterin can be a direct
participant within the cascade of events leading to oxidative
stress. In clinical conditions with increased neopterin concen-
trations such as viral infections including HIV infection, var-
ious malignant disorders, autoimmune diseases and allograft
rejections, activation of di¡erent immunocompetent cells is
obvious. It is know that neutrophils of human peripheral
blood generate ROS when activated, for example, by adhesion
on glass or in£uence of a number of phagocytosis-stimulating
factors [11]. This study provides ¢rst results on the in£uence
of neopterin to interfere with neutrophils to generate ROS.
2. Materials and methods
2.1. Chemicals
Superoxide dismutase (SOD), 2-phenyl-4,4,5,5-tetramethylimidazo-
line-1-oxyl-3-oxide (PTIO), D-mannitol, luminol (5-amino-2,3-dihy-
dro-1,4-phthalazinedione), and lucigenin (bis-N-methylacridinium ni-
trate) were from Sigma (Munich, Germany). L-histidine (L-K-amino-L-
[4-imidazolyl]propionic acid) was from Reanal (Budapest, Hungary).
Diazabicyclo[2.2.2]octane (DABCO) was from Merck (Darmstadt,
Germany). Neopterin was from Dr. Schircks Laboratories (Jona,
Switzerland).
2.2. Experimental procedure
Neutrophils were isolated from heparinized peripheral blood of
healthy donors by centrifugation using Ficoll-verogra¢n density gra-
dient [12]. Lysis of remaining erythrocytes was carried out with cold
distilled water during 20 s. Then cells were washed twice in 0.15 M
NaCl and were resuspended in Earl’s balanced salt solution
(pH=7.2). The cell preparations contained more than 96% of neutro-
phils, and 106 cells/ml were stored at 4‡C.
The generation of ROS in neutrophils was studied by a luminol-
and lucigenin-dependent chemiluminescence method with use of bio-
chemiluminometer BCL-1 (Belarus State University, Belarus) [13].
Luminol-dependent chemiluminescence (LDCL) was studied under
adhesion of cells to the bottom of a cylindrical glass cuvette (diameter
40 mm). The volume of the cellular suspension was 2.4 ml, the con-
centration of neutrophils in the cuvette was 105 cells/ml.
Neopterin (250 WM) was freshly dissolved in 0.15 M NaCl by in-
cubation for 1 h at 37‡C. Measurements were carried out in Earl’s
0014-5793 / 03 / $22.00 J 2003 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.
doi:10.1016/S0014-5793(03)00796-8
*Corresponding author.
E-mail address: julikby@yahoo.com (J.A. Razumovitch).
Abbreviations: DABCO, diazabicyclo[2.2.2]octane; GTP, guanosine
triphosphate; LDCL, luminol-dependent chemiluminescence; PTIO,
2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide; ROS, reactive
oxygen species; SOD, superoxide dismutase
FEBS 27508 30-7-03
FEBS 27508 FEBS Letters 549 (2003) 83^86
solutions (pH=7.2) by addition of 5 mM CaCl2 at 37‡C. Concentra-
tion of luminol and lucigenin was 0.5 WM. The bottom of the cuvette
was covered by a layer of 20% Ficoll solution in 0.15 M NaCl (thick-
ness of layer 2 mm) in the experiments with impeding the adhesion of
cells. The ROS scavengers SOD, PTIO, DABCO, D-mannitol, L-his-
tidine and their combinations were used. All scavengers were dis-
solved in the 0.15 M NaCl in the following concentrations, which
had been determined in pilot experiments: 0.3 WM SOD, 32 WM
PTIO, 0.5 mM D-mannitol, 0.2 mM DABCO, 0.3 mM L-histidine.
2.3. Calculation
The cell mixtures containing neopterin were compared to the con-
trol specimens without neopterin. Mean valuesN standard errors of
the mean were calculated from 10 independent sets for di¡erent do-
nors. Statistical analysis was performed using Student’s t-test.
3. Results
Typical LDCL kinetics of activated neutrophils at adhesion
to glass surface are presented in Fig. 1 (curve 1). Fig. 1 also
summarizes the e¡ects of neopterin on LDCL of neutrophils
during their adhesion to glass (curves 2^7). The kinetics of
neopterin-induced LDCL responses in cells depended on the
time after beginning of neutrophil adhesion and had two
phases. The ¢rst maximum light output was achieved 2^3
min after addition of neopterin to the cells. The second phase
appeared after 4^5 min from the time when neopterin was
added. The appearance of the second phase depended on
the concentration of neopterin (see below) and the time
from addition of neopterin in the cuvette. The second phase
was characterized by a lower rate of ROS generation and
longer duration as compared with the ¢rst phase. Neopterin
a¡ected only adhesive cells and/or cells generating ROS. In
conditions impeding the adhesion of cells (neutrophils strati-
¢ed on 20% Ficoll solution), generation of ROS did not take
place (data not shown).
Neopterin enhanced ROS formation in a concentration-
and time-dependent manner (Fig. 2). 20 WM concentration
was selected as working solution, concentrations lower than
5 WM of neopterin had no signi¢cant e¡ect.
Changes in chemiluminescence intensity of neutrophil sus-
pensions upon addition of neopterin were observed in the
presence of luminol, but not of lucigenin.
Superoxide scavenger SOD and nitric oxide scavenger PTIO
decreased LDCL. However, only the second phase of neutro-
phil responses was inhibited whereas the ¢rst phase remained
unchanged (Fig. 3). Singlet oxygen scavenger DABCO in cel-
lular suspensions led to noticeable increase of LDCL intensity
during neutrophil adhesion. Hydroxyl radical scavenger
D-mannitol and L-histidine (scavenger of hydroxyl radical and
singlet oxygen) insigni¢cantly decreased this readout (data not
shown). Addition of neopterin into the suspension of the cells
containing D-mannitol, L-histidine and DABCO decreased the
intensity of LDCL of neutrophils (Fig. 4).
4. Discussion
Stimulated neutrophils of healthy donors are known to gen-
erate ROS. This e¡ect can be studied by monitoring of
LDCL. Typical kinetic curves of LDCL of neutrophils acti-
vated by the attachment to glass surface had a two-stage
character. As discussed earlier [14,15] the ¢rst stage was
caused by activation of redox systems formed in plasma mem-
brane. NADPH-oxidase localized in the plasma membrane
reduced oxygen to superoxide anion radicals, which sponta-
neously dismuted to hydrogen peroxide and oxygen [16].
Superoxide anion and hydrogen peroxide were precursors
for many other reactive species such as singlet oxygen, hy-
droxyl radicals, hypochlorous acid which could interact with
Fig. 1. Total intensity of luminol-induced chemiluminescence in control neutrophils and after addition of neopterin (arrows indicate the mo-
ment of neopterin addition).
Fig. 2. Dose-dependent change of maximal intensity of luminol-in-
duced chemiluminescence (¢rst phase) in neutrophils (increasing
compared to controls without neopterin added).
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each other and with cell components [17]. The second stage is
associated with the involvement of intracellular enzymes, in-
cluding myeloperoxidase system or NADPH-oxidase of secre-
tory and speci¢c granule membranes [14]. The ¢rst stage con-
tinued for about 6 min and we could not observe any
in£uence of neopterin at this stage. The second stage reached
a maximum from 30^40 min after the beginning of adhesion.
The ratio of these stages could change in di¡erent donors due
to individual properties. Our data demonstrate that neopterin
in£uences the generation of ROS by neutrophils only at the
second stage (Fig. 1). The greatest response was obtained at
the maximum of the second stage, i.e. at maximal ROS gen-
eration of neutrophils.
Lucigenin is a speci¢c indicator for the production of super-
oxide anions. Lucigenin-dependent chemiluminescence was
absent in neutrophils at the action of neopterin (data not
shown), which excludes any participation of NADPH-oxidase
of plasma membrane in the response of neutrophils. This is
con¢rmed also by the ¢nding that SOD did not inhibit the
¢rst phase of neopterin-induced neutrophil response. SOD
cannot penetrate through plasma membranes and therefore
can interact only with superoxide which is produced by en-
zymes at the cell surface or which penetrates through cell
membranes. Lack of inhibitory action of SOD on the ¢rst
phase of neopterin-induced neutrophil LDCL could indicate
that NADPH-oxidase localized in the plasma membrane did
not participate in neopterin-induced ROS generation in this
period. Considerable reduction of LDCL intensity at the sec-
ond phase of response rather is associated with superoxide
production by intracellular enzymatic systems.
Fig. 3. Typical kinetics of luminol-induced chemiluminescence of neutrophils under adhesion to glass (neutrophil adhesion) and addition of neo-
pterin (diamonds), in£uence of SOD on neutrophil adhesion (neutrophil adhesion+SOD) and on addition of neopterin (triangles) and in£uence
of PTIO on neutrophil adhesion (neutrophil adhesion+PTIO) and on addition of neopterin (squares). Arrows indicate the moment of neopterin
addition. The insert depicts the relative magnitude of neopterin-induced changes of luminol-induced chemiluminescence in neutrophils.
Fig. 4. E¡ects of neopterin on luminol-induced chemiluminescence in the absence and in the presence of scavengers of ROS.
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PTIO signi¢cantly decreased LDCL intensity of neutro-
phils. Data indicated the participation of nitric oxide in neo-
pterin-induced cell response. Still PTIO did not in£uence neo-
pterin-induced lucigenin-dependent chemiluminescence. With
this respect it might be of relevance that neopterin was found
earlier to induce nitric oxide synthase gene expression and
nitric oxide production in rat vascular smooth muscle cells
[18]. Peroxynitrite is the product of the reaction of nitric oxide
with superoxide and it can serve as the important mediator of
tissue injury during conditions associated with enhanced nitric
oxide and superoxide production [19]. If superoxide, acquired
by neopterin action, had been completely transformed into
peroxynitrite, lucigenin-dependent chemiluminescence would
have been increased by PTIO. The absent in£uence of PTIO
on neopterin-induced lucigenin-dependent chemiluminescence
proved that neopterin did not activate superoxide-generating
system in neutrophils.
The neutrophil response on neopterin was greatly decreased
in the presence of D-mannitol. This fact suggests a contribu-
tion of hydroxyl radical in neopterin-induced LDCL in neu-
trophils. Similar results were received in the presence of
L-histidine, scavenger of hydroxyl radical and singlet oxygen.
It was known that superoxide anion is both a source and an
e⁄cient quencher of singlet oxygen [20]. Therefore an increase
of neutrophil LDCL intensity during adhesion in the presence
of DABCO could explain enlarged superoxide amount in a
cuvette. Decrease of LDCL intensity of neutrophil suspension
containing DABCO after the addition of neopterin could be
explained by neopterin activation of singlet generation path-
way. The in£uence of scavengers shows that neopterin induces
singlet oxygen and hydroxyl radical generation in neutrophils.
Interestingly spontaneous formation of hydroxyl radicals in
aqueous solutions of neopterin derivatives has been demon-
strated earlier also in cell-free experiments using, e.g. electron
spin resonance [21,22]. Recently, 6-substituted pteridines in-
cluding neopterin were found to induce singlet oxygen in also
aqueous solutions [23].
The observation that neopterin, a product of monocyte-de-
rived macrophages upon stimulation with interferon-Q, is able
to induce singlet oxygen in granulocytes is of special interest.
It is well in line with the observation that Th1-type cytokine
interferon-Q enhances antifungal activity of granulocytes by
means of enhancing oxidative burst [23]. Data add also to
the observation that neopterin is able to enhance the produc-
tion and e⁄cacy of toxic compounds during immune response
[5^10]. Likewise, neopterin concentrations have been found to
be associated with measures of oxidative stress in various
diseases such as infection, autoimmunity and malignancy
[24], and neopterin concentrations correlate with the course
of such diseases and predict prognosis [3,4,25].
In summary, the results of this study suggest that neopterin
does not activate NADPH-oxidase of plasma membrane in
the neutrophils and that the neutrophils respond on exposure
to neopterin with additional generation of singlet oxygen, hy-
droxyl radical and nitric oxide by NADPH-independent path-
ways.
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